1. Repository of OAI
Ελληνικά   English  

Browsing by Author Mikhailidis, D. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 84 to 103 of 130 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Orlistat-associated adverse effects and drug interactions: a critical reviewFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Nakou, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Pathogenesis, detection and treatment of Achilles tendon xanthomasTsouli, S. G.; Kiortsis, D. N.; Argyropoulou, M. I.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Pharmacological treatment of non-alcoholic steatohepatitis: the current evidenceDiakou, M. C.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tsianos, E. V.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
Platelet function and lipid-lowering interventionsMilionis, H. J.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosisMilionis, H. J.; Mikhailidis, D. P.; Winder, A. F.24-Nov-2015-
Platelets as predictors of vascular risk: is there a practical index of platelet activity?Tsiara, S.; Elisaf, M. S.; Jagroop, I. A.; Mikhailidis, D. P.24-Nov-2015-
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevationFlorentin, M.; Liberopoulos, E. N.; Kei, A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of thiazolidinedionesRizos, C. V.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The predictive value of lipid markers in vascular diseaseMilionis, H. J.; Daskalopoulou, S. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S.24-Nov-2015-
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measuresLiberopoulos, E. N.; Tsouli, S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Prevention and treatment of the metabolic syndromeDaskalopoulou, S. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Regarding "smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction"Milionis, H. J.; Jeremy, J. Y.; Mikhailidis, D. P.24-Nov-2015-
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol loweringDerdemezis, C. S.; Filippatos, T. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
A review of the lipid-related effects of fluvastatinLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Wierzbicki, A. S.; Elisaf, M. S.24-Nov-2015-
A review of the metabolic effects of sibutramineFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Review: Antiplatelet drugs: what comes next?Kei, A. A.; Florentin, M.; Mikhailidis, D. P.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015-
The role of thiols in liver ischemia-reperfusion injuryGlantzounis, G. K.; Yang, W.; Koti, R. S.; Mikhailidis, D. P.; Seifalian, A. M.; Davidson, B. R.24-Nov-2015-
Showing results 84 to 103 of 130 < previous   next >